Cowen Prime Advisors LLC Neogenomics Inc Transaction History
Cowen Prime Advisors LLC
- $287 Million
- Q2 2023
A detailed history of Cowen Prime Advisors LLC transactions in Neogenomics Inc stock. As of the latest transaction made, Cowen Prime Advisors LLC holds 38,400 shares of NEO stock, worth $679,296. This represents 0.22% of its overall portfolio holdings.
Number of Shares
38,400
Previous 40,800
5.88%
Holding current value
$679,296
Previous $597,000
3.35%
% of portfolio
0.22%
Previous 0.24%
Shares
6 transactions
Others Institutions Holding NEO
# of Institutions
293Shares Held
124MCall Options Held
698KPut Options Held
120K-
Black Rock Inc. New York, NY19.7MShares$348 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14MShares$248 Million0.0% of portfolio
-
Brown Advisory Inc6.89MShares$122 Million0.13% of portfolio
-
Janus Henderson Group PLC London, X06.6MShares$117 Million0.05% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.54MShares$116 Million0.06% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $2.23B
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...